A4250, an IBAT Inhibitor in Pediatric Cholestasis

The Role of Ursodeoxycholic Acid in Treatment of Gallstones in Hemolytic Disorders

NCT02472509 ·Status: TERMINATED ·Phase: PHASE4

Molecular Characterization for Understanding Biliary Atresia

NCT04272515 ·Status: RECRUITING ·Phase: NA

BILACO Trial: Biliary Atresia - a Severe Complex Congenital Liver Disease

NCT05399745 ·Status: RECRUITING

Efficacy and Safety of S-adenosyl-l-methionine in Treatment of Alcoholic Hepatitis With Cholestasis

NCT02024295 ·Status: UNKNOWN ·Phase: PHASE4

Cholic Acid for Hepatic Steatosis in Lipodystrophy

NCT00457639 ·Status: COMPLETED ·Phase: PHASE2

Phase 3 Study of Obeticholic Acid in Patients With Primary Biliary Cirrhosis

NCT01473524 ·Status: COMPLETED ·Phase: PHASE3

Fibrates in Pediatric Cholestasis

NCT03586674 ·Status: COMPLETED ·Phase: PHASE2

Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Obeticholic Acid (OCA) Compared to Placebo in Pediatric Participants With Biliary Atresia, Post-hepatoportoenterostomy

NCT06121375 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Combination Therapy With Ursodeoxycholic Acid (UDCA) and All-Trans Retinoic Acid (ATRA) for Treatment of Primary Sclerosing Cholangitis

NCT01456468 ·Status: COMPLETED ·Phase: PHASE1

A Study Evaluating the Safety, Tolerability, and Efficacy of Aramchol Meglumine in Primary Sclerosing Cholangitis

NCT06095986 ·Status: WITHDRAWN ·Phase: PHASE2

Validation of the Itch Reported Outcome (ItchRO) Diaries in Pediatric Cholestatic Liver Disease

NCT02131623 ·Status: COMPLETED

A Placebo-controlled Study of Volixibat in Subjects With Elevated Serum Bile Acids Associated With Intrahepatic Cholestasis of Pregnancy (OHANA)

NCT04718961 ·Status: TERMINATED ·Phase: PHASE2

Efficacy and Safety of S-adenosyl-L-methionine in Treatment of Chronic Hepatitis B Patients With Cholestasis

NCT01998620 ·Status: UNKNOWN ·Phase: PHASE4

A Pilot Study of Acarbose as Treatment for Pediatric Non-alcoholic Fatty Liver Disease (NAFLD)

NCT00677521 ·Status: TERMINATED ·Phase: PHASE2

Enteral Fish Oil is Superior to Ursodeoxycholic Acid (UDCA) and Placebo for the Treatment of Cholestasis in Infants

NCT02420496 ·Status: WITHDRAWN ·Phase: PHASE2

Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD)

NCT04336722 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Colesevelam Versus Placebo in Cholestatic Pruritus

NCT00756171 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Phase II Pilot Study to Compare the Bioavailability of Buffered, Enteric-Coated Ursodiol With Unmodified Ursodiol for Chronic Cholestatic Liver Disease and Cystic Fibrosis-Associated Liver Disease

NCT00004315 ·Status: UNKNOWN ·Phase: PHASE2

Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Participants With Primary Biliary Cirrhosis

NCT01865812 ·Status: COMPLETED ·Phase: PHASE2

An Efficacy Trial of Low Dose All-trans Retinoic Acid in Patients With Primary Sclerosing Cholangitis

NCT03359174 ·Status: TERMINATED ·Phase: PHASE2

Trial of Obeticholic Acid in Patients With Moderately Severe Alcoholic Hepatitis (AH)

NCT02039219 ·Status: TERMINATED ·Phase: PHASE2

BSEP Function Rescue During Childhood Inhereditary Cholestatic Diseases

NCT04531878 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3

Effect of Obeticholic Acid on Transport of Bile Acids in PBC Examined by 11C-cholyl-sarcosine PET/CT

NCT03253276 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Study to Evaluate Patients With Cerebrotendinous Xanthomatosis (RESTORE)

NCT04270682 ·Status: COMPLETED ·Phase: PHASE3

A Trial of 18-22mg/kg/d Ursodeoxycholic in Refractory Primary Biliary Cholangitis

NCT03345589 ·Status: UNKNOWN ·Phase: PHASE4